MTEMMolecular Templates, Inc.

Nasdaq www.thresholdpharm.com


$ 1.48 $ -0.05 (-3.33 %)    

Friday, 17-May-2024 12:55:03 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 1.45
$ 1.46
$ 0.00 x 0
$ 0.00 x 0
$ 1.46 - $ 1.48
$ 1.27 - $ 9.45
21,564
na
10.17M
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-19-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-30-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 07-31-2017 06-30-2017 10-Q
29 05-16-2017 03-31-2017 10-Q
30 03-27-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-01-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-10-2016 12-31-2015 10-K
35 11-02-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 03-03-2015 12-31-2014 10-K
39 11-03-2014 09-30-2014 10-Q
40 08-01-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 molecular-templates-q1-2024-gaap-eps-008-beats-078-estimate-sales-1109m-beat-590m-estimate

Molecular Templates (NASDAQ:MTEM) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $...

 molecular-templates-inc-estimates-that-it-will-incur-aggregate-pre-tax-charges-of-01m-in-connection-with-reduction-in-force-effective-april-30-reduction-to-extend-resources-to-allow-co-to-continue-to-support-clinical-studies-for-mt-6402-mt-8421-and-mt-0169

- SEC Filing

 molecular-templates-inc-says-reduction-in-force-would-reduce-companys-current-workforce-by-30-approved-a-reduction-in-force-expects-that-reduction-in-force-will-be-complete-by-end-of-april-2024

-SEC Filing 

 whats-going-on-with-molecular-templates-stock

Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients...

 molecular-templates-presents-interim-data-from-mt-6402-phase-i-study-in-patients-with-pd-l1-solid-tumors-at-2024-aacr-annual-meeting

The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:MT-6402 has been well tolerated...

 top-5-health-care-stocks-which-could-rescue-your-portfolio-in-march

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 molecular-templates-q3-eps-082-beats-139-estimate-sales-573m-beat-246m-estimate

Molecular Templates (NASDAQ:MTEM) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $...

 why-wynn-resorts-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

 molecular-templates-announces-first-patient-dosed-in-phase-1-trial-evaluating-mt-8421-a-novel-engineered-toxin-body-targeting-ctla-4-in-advanced-solid-tumors

Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")))), a clinical-stage biopharmaceutic...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION